The 'not invented here' myth

Nature Reviews Drug Discovery

Volumn 5, Issue 6, 2006, Pages 451-452

  Lou, Kasper ^a   de Rond, Mark ^b  

^a Business Development for GEP Process Engineering   (Denmark)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NEW DRUG; DRUG;

BIOTECHNOLOGY; DOCUMENTATION; DRUG APPROVAL; DRUG DESIGN; DRUG EFFICACY; DRUG INDUSTRY; DRUG INFORMATION; DRUG MARKETING; DRUG RESEARCH; DRUG SAFETY; LICENSING; NOTE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROBABILITY; STANDARDIZATION; ARTICLE; COOPERATION;

BIOTECHNOLOGY; COOPERATIVE BEHAVIOR; DRUG APPROVAL; DRUG INDUSTRY; LICENSURE; PHARMACEUTICAL PREPARATIONS;

EID: 33745948008     PISSN: 14741776     EISSN: 14741784     Source Type: Journal    
DOI: 10.1038/nrd2063     Document Type: Note

References (7)

1. Pavlou, A. K. & Belsey, M. J. From the analyst's couch: Biopharma licensing and M&A trends. Nature Rev. Drug Discov. 4, 273-274 (2005).
2. PriceWaterhouseCoopers. High-performing strategic alliances in the pharmaceutical, biotechnology and medical device and diagnostic industries [online], (1999)
3. Kogut, B. in Co-operative Strategies in International Business (eds Contractor, F. J. & Lorange, P.) 169-185 (Lexington, Massachusetts, 1988).
4. Jones, A. & Clifford, L. From the analyst's couch: Drug discovery alliances. Nature Rev. Drug Discov. 4, 807-808 (2005).
5. DiMasi, J. A. Risks in new drug development: Approval success rates for investigational drugs. Clin. Pharmacol. Ther. 69, 297-307 (2001).
6. Gambardella, A., Orsenigo, L. & Pammolli, F. Global competitiveness in pharmaceuticals: A European perspective [online], < http://europa.eu.int/ comm/enterprise/library/enterprise-papers/paper1.htm > (2001).
7. CMR International 2005/2006 Pharmaceutical R&D Fact Book. Centre for Medicines Research International Ltd [online], < http://www.cmr.org> (2005).